|
Variable
|
n = 69 (%)
|
|---|
|
Age (years)
|
|
Median (range)
|
69 (40–85)
|
|
Gender
|
|
Male
|
60 (87)
|
|
Female
|
9 (13)
|
|
Performance status
|
|
0
|
12 (17)
|
|
1
|
46 (67)
|
|
2
|
10 (15)
|
|
3
|
1 (1)
|
|
Tumor type, TNMa
|
|
Nasopharyngeal ca.
|
5 (7)
|
|
T1N2M0
|
1
|
|
T1N3M0
|
1
|
|
T2N1M0
|
3
|
|
Oropharyngeal ca.
|
15 (22)
|
|
T1N0M0
|
1
|
|
T1N2M0
|
4
|
|
T2N0M0
|
1
|
|
T2N1M0
|
2
|
|
T2N2M0
|
1
|
|
T3N1M0
|
1
|
|
T4N1M0
|
1
|
|
T4N2M0
|
1
|
|
T4N3M0
|
3
|
|
Hypopharyngeal ca.
|
22 (32)
|
|
T1N0M0
|
2
|
|
T1N2M0
|
1
|
|
T2N0M0
|
8
|
|
T2N1M0
|
1
|
|
T2N2M0
|
4
|
|
T3N2M0
|
2
|
|
T4N0M0
|
2
|
|
T4N2M0
|
2
|
|
Laryngeal ca.
|
27 (39)
|
|
T2N0M0
|
22
|
|
T2N1M0
|
1
|
|
T2N2M0
|
2
|
|
T3N0M0
|
1
|
|
T3N2M0
|
1
|
-
aInternational Union Against Cancer tumor, node, metastasis classification, 6th edition
